Statement Of Cash Flows [Abstract]

PureTech Health plc - Filing #1607985

Concept	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	2019-01-01 to 2019-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for decrease (increase) in trade and other receivables	617,000 USD	529,000 USD	747,000 USD
Adjustments for decrease (increase) in other assets	— USD	— USD	48,000 USD
Adjustments for decrease (increase) in other current assets	5,350,000 USD	3,371,000 USD	25,000 USD
Adjustments for gains (losses) on change in fair value of derivatives	800,000 USD	— USD	— USD
Adjustments for gain (loss) on disposals, property, plant and equipment	53,000 USD	66,000 USD	140,000 USD
Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates	— USD	— USD	264,409,000 USD
Adjustments for undistributed profits of investments accounted for using equity method	73,703,000 USD	34,117,000 USD	30,791,000 USD
Cash flows from (used in) investing activities [abstract]
Purchase of investments other than investments accounted for using equity method	— USD	10,000,000 USD	13,670,000 USD
Purchase of financial instruments, classified as investing activities	— USD	— USD	69,541,000 USD
Proceeds from sales or maturity of financial instruments, classified as investing activities	— USD	30,116,000 USD	173,995,000 USD
Cash flows from (used in) financing activities [abstract]
Proceeds from exercise of options	352,000 USD	1,036,000 USD	504,000 USD
Proceeds from issue of preference shares	37,610,000 USD	13,750,000 USD	51,048,000 USD
Proceeds from non-current borrowings	— USD	14,720,000 USD	— USD
Repayments of non-current borrowings	— USD	— USD	178,000 USD
Proceeds from current borrowings	— USD	68,000 USD	— USD
Proceeds from issue of bonds, notes and debentures	2,215,000 USD	25,000,000 USD	1,606,000 USD